Angela Cheng-Lai

560 total citations
32 papers, 398 citations indexed

About

Angela Cheng-Lai is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Economics and Econometrics. According to data from OpenAlex, Angela Cheng-Lai has authored 32 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 14 papers in Cardiology and Cardiovascular Medicine and 5 papers in Economics and Econometrics. Recurrent topics in Angela Cheng-Lai's work include Lipoproteins and Cardiovascular Health (9 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Computational Drug Discovery Methods (4 papers). Angela Cheng-Lai is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Computational Drug Discovery Methods (4 papers). Angela Cheng-Lai collaborates with scholars based in United States and United Kingdom. Angela Cheng-Lai's co-authors include William H. Frishman, Wilbert S. Aronow, James J. Nawarskas, Julie Chen, Jason R. Chan, Henny H. Billett, Serena Wong, Bhaumik B. Patel, Philip Chung and Hillel W. Cohen and has published in prestigious journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Annals of Pharmacotherapy and American Journal of Health-System Pharmacy.

In The Last Decade

Angela Cheng-Lai

32 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angela Cheng-Lai United States	13	160	117	69	60	49	32	398
Csaba András Dézsi Hungary	13	290 1.8×	101 0.9×	62 0.9×	53 0.9×	32 0.7×	38	487
W. Dieter Paar Germany	12	333 2.1×	103 0.9×	135 2.0×	54 0.9×	55 1.1×	34	539
Paul H. Trienekens Netherlands	9	80 0.5×	52 0.4×	64 0.9×	38 0.6×	62 1.3×	14	355
Michael Ward Australia	11	107 0.7×	80 0.7×	29 0.4×	41 0.7×	13 0.3×	50	436
Luis A. Álvarez-Sala Spain	10	117 0.7×	88 0.8×	74 1.1×	49 0.8×	9 0.2×	24	437
Cheryle Gurk‐Turner United States	10	149 0.9×	165 1.4×	49 0.7×	68 1.1×	35 0.7×	18	613
Ariola Koci Italy	10	111 0.7×	41 0.4×	29 0.4×	51 0.8×	19 0.4×	16	386
Lee Schwocho United States	5	202 1.3×	99 0.8×	98 1.4×	50 0.8×	72 1.5×	6	350
Christopher N. Floyd United Kingdom	13	329 2.1×	87 0.7×	51 0.7×	30 0.5×	91 1.9×	30	505
Jamshed Dalal India	17	544 3.4×	245 2.1×	120 1.7×	71 1.2×	41 0.8×	80	880

Countries citing papers authored by Angela Cheng-Lai

Since Specialization

Citations

This map shows the geographic impact of Angela Cheng-Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Cheng-Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Cheng-Lai more than expected).

Fields of papers citing papers by Angela Cheng-Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Cheng-Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Cheng-Lai. The network helps show where Angela Cheng-Lai may publish in the future.

Co-authorship network of co-authors of Angela Cheng-Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Cheng-Lai. A scholar is included among the top collaborators of Angela Cheng-Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Cheng-Lai. Angela Cheng-Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng-Lai, Angela, et al.. (2022). Evaluating Pharmacist-Led Heart Failure Transitions of Care Clinic: Impact of Analytic Approach on Readmission Rate Endpoints. Current Problems in Cardiology. 48(2). 101507–101507. 3 indexed citations

Nawarskas, James J., et al.. (2020). Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019. Cardiology in Review. 28(4). 213–216. 9 indexed citations

Chan, Jason R. & Angela Cheng-Lai. (2017). Inhaled Insulin. Cardiology in Review. 25(3). 140–146. 18 indexed citations

Chung, Philip, et al.. (2016). Evaluation of adherence to current guidelines for treatment of hyperlipidemia in adults in an outpatient setting. American Journal of Health-System Pharmacy. 73(23_Supplement_6). S133–S140. 8 indexed citations

Frishman, William H., et al.. (2016). Patiromer. Cardiology in Review. 24(6). 316–323. 4 indexed citations

Cheng-Lai, Angela, et al.. (2016). Edoxaban. Cardiology in Review. 24(4). 205–210. 1 indexed citations

Patel, Bhaumik B., et al.. (2014). Pulmonary Arterial Hypertension. Cardiology in Review. 23(1). 33–51. 10 indexed citations

Cheng-Lai, Angela, et al.. (2012). The Polypill. Cardiology in Review. 21(1). 49–54. 9 indexed citations

Cheng-Lai, Angela, et al.. (2012). Clopidogrel and Genetic Testing. Cardiology in Review. 20(2). 96–100. 8 indexed citations

10.

Cheng-Lai, Angela, et al.. (2011). Dabigatran Etexilate. Cardiology in Review. 19(3). 154–161. 24 indexed citations

11.

Cheng-Lai, Angela, et al.. (2009). Dronedarone. Cardiology in Review. 17(5). 230–234. 6 indexed citations

12.

Cheng-Lai, Angela, et al.. (2009). Clevidipine. Cardiology in Review. 17(3). 147–152. 10 indexed citations

13.

Cheng-Lai, Angela, et al.. (2008). A comparison of direct thrombin inhibitors in the treatment of heparin-induced thrombocytopenia: a single institution experience. Journal of Thrombosis and Thrombolysis. 28(2). 117–123. 11 indexed citations

14.

Aronow, Wilbert S., William H. Frishman, & Angela Cheng-Lai. (2007). Cardiovascular Drug Therapy in the Elderly. Cardiology in Review. 15(4). 195–215. 30 indexed citations

15.

Cheng-Lai, Angela, et al.. (2005). Peak Antifactor Xa Activity Produced by Dalteparin Treatment in Patients with Renal Impairment Compared with Controls. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(6). 817–822. 22 indexed citations

16.

Cheng-Lai, Angela & William H. Frishman. (2004). Sirolimus-Eluting Coronary Stents: Novel Devices for the Management of Coronary Artery Disease. American Journal of Therapeutics. 11(3). 218–228. 12 indexed citations

17.

Cheng-Lai, Angela. (2003). Rosuvastatin: A New HMG-CoA Reductase Inhibitor for the Treatment of Hypercholesterolemia. PubMed. 5(1). 72–78. 29 indexed citations

18.

Cheng-Lai, Angela. (2002). Cardiovascular drug highlight: hirudin.. PubMed. 1(1). 41–9. 7 indexed citations

19.

Cheng-Lai, Angela. (2002). Cerivastatin.. PubMed. 2(1). 93–9. 1 indexed citations

20.

Cheng-Lai, Angela. (2002). Eprosartan. PubMed. 4(1). 54–59. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact